 PROLOR Biotech Awarded Israeli Government Grant of up to $1.6 Million for Its Longer-Acting Human Growth Hormone Program. - PR Newswire | HighBeam Research 

   Search  Options   Cancel changes All of these words This exact phrase  Any of these words None of these words  Apply Cancel       Follow us:      Subscription benefits  Log in        Sign up for a free, 7-day trial     Browse publications     Browse topics        Topics home  People     Company executives    Historical figures    Politicians and Government officials        Issues and Events  Places  Organizations  A-Z     A-G    H-O    P-T    U-Z    0-9           Publications home  Journals    Academic journals  Business journals  Education journals  Math and Engineering journals  Medical journals  Science and Technology journals  Trade journals       Magazines    Business magazines  Computer magazines  Education magazines  Industry magazines  Lifestyle magazines  Medical magazines       Newspapers    International newspapers and newswires  Reports, newsletters, and transcripts  U.K. newspapers  U.S. newspapers and newswires       Reference works and books    Almanacs  Dictionaries and thesauruses  Encyclopedias  Non-fiction books             Home »  Publications »  U.S. newspapers and newswires »  U.S. newswires »  PR Newswire »  Apr - Jun 2010 »  April 12, 2010 »   Save  This article has been saved! You may organize and add notes about this article below.       This article has been saved! View all saved articles     Export    To export this article to Microsoft Word, please log in or subscribe.  Have an account?  Please log in  Not a subscriber?  Sign up today   To export this article to Microsoft Word, please  reactivate your account .       Email          Recipient's email address 
 Use commas to separate email addresses. This information will  not be used for marketing purposes. Your email address  Send me a copy too.   Comments  (optional)  
I thought you might find this article from HighBeam Research interesting. (1000 characters remaining)        Print  Cite    MLA  " PROLOR Biotech Awarded Israeli Government Grant of up to $1.6 Million for Its Longer-Acting Human Growth Hormone Program. "  PR Newswire . PR Newswire Association LLC. 2010.  HighBeam Research. 18 Nov. 2011 < http://www.highbeam.com > .  Chicago  "PROLOR Biotech Awarded Israeli Government Grant of up to $1.6 Million for Its Longer-Acting Human Growth Hormone Program."  PR Newswire . 2010.  HighBeam Research. (November 18, 2011).  http://www.highbeam.com/doc/1G1-223649269.html   APA  "PROLOR Biotech Awarded Israeli Government Grant of up to $1.6 Million for Its Longer-Acting Human Growth Hormone Program."  PR Newswire . PR Newswire Association LLC. 2010. Retrieved November 18, 2011 from HighBeam Research:  http://www.highbeam.com/doc/1G1-223649269.html    Please use HighBeam citations as a starting point only. Not all required citation information is available for every article, and citation requirements change over time.     Permalink    Create a link to this page Copy and paste this link tag into your Web page or blog: <a href="http://www.highbeam.com/doc/1G1-223649269.html" title="PROLOR Biotech Awarded Israeli Government Grant of up to $1.6 Million for Its Longer-Acting Human Growth Hormone Program. | HighBeam Research">PROLOR Biotech Awarded Israeli Government Grant of up to $1.6 Million for Its Longer-Acting Human Growth Hormone Program.</a>      PROLOR Biotech Awarded Israeli Government Grant of up to $1.6 Million for Its Longer-Acting Human Growth Hormone Program.   PR Newswire      See all results for this publication  Browse back issues of this publication by date      April 12, 2010 |  Copyright COPYRIGHT 2009 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights or concerns about this content should be directed to  Customer Service .            NES-ZIONA, Israel, April 12 /PRNewswire-FirstCall/ -- PROLOR Biotech, Inc. (NYSE Amex: PBTH), a company developing next generation biobetter therapeutic proteins, today announced that the Israeli Office of the Chief Scientist ("OCS") has approved a 2010 continuation of its grant to PROLOR's Israeli-based R&D subsidiary for the company's development program for hGH-CTP, its proprietary longer-acting version of human growth hormone (hGH). Human growth hormone is indicated for the long-term treatment of children and adults with growth hormone deficiency due to inadequate secretion of endogenous growth hormone. hGH is also sometimes used to counter involuntary weight loss and for certain physical manifestations of aging. Currently available forms of hGH must be injected daily. In contrast, clinical data to date suggests that hGH-CTP, PROLOR's biobetter form of growth hormone, has the potential to require only bi-monthly or weekly injections. Current global sales of human growth hormone products are estimated at about $3 billion annually. …    To read the full text of this article and others like it, try us out for 7 days, FREE!      Related articles  on HighBeam Research  Searching…   See all related articles »      Publication Finder Browse back issues from our extensive library of more than 6,500 trusted publications.    Popular publications on HighBeam Research  Jerusalem Post   Asian newspapers   Crain's New York Business   Management magazines   M2 Presswire   International newswires   Harper's Magazine   Cultural magazines   Chicago Sun-Times   Illinois newspapers    Help us improve our websites Become a member of our Customer Advisory Panel. Your opinion matters! Join the panel    <script src="http://ad.doubleclick.net/N6334/adj/gale.hbr.doc/p3672;page=wall;cat=hbr_2143;pub=p3672;pos=r1;channel=1000000024;sz=300x250;ord=2100863757;" type="text/javascript"> </script> <noscript> <a href="http://ad.doubleclick.net/N6334/jump/gale.hbr.doc/p3672;page=wall;cat=hbr_2143;pub=p3672;pos=r1;channel=1000000024;sz=300x250;ord=2100863757;" target="_blank"> <img src="http://ad.doubleclick.net/N6334/ad/gale.hbr.doc/p3672;page=wall;cat=hbr_2143;pub=p3672;pos=r1;channel=1000000024;sz=300x250;ord=2100863757;" border="0" alt="" /> </a> </noscript>              Company  About us  Subscription benefits  Careers  Privacy policy  Terms and conditions  Contact us   Help topics  FAQ  Search tips  Using the Research Center  Billing questions  Rights inquiries  Customer Service   From our blog  All posts  Trending news  Research  How-to guides  News and updates  Testimonials   Cengage Learning Network  Questia  CengageBrain.com  HighBeam Business  Encyclopedia.com  ed2go     HighBeam Research Follow us:       HighBeam Research is operated by  Cengage Learning . © Copyright 2011. All rights reserved. The HighBeam advertising network includes:  womensforum.com GlamFamily                
